MSH2 and endometrial cancer: Among individuals who met Medicare testing criteria, the most commonly affected gene was MSH2 followed by MSH6 and MLH1. Although MSH2 and MLH1 are highly penetrant and expected to represent a large proportion of classic LS families, the larger number of MSH6 variants identified in this study could be due to testing of women with personal history of endometrial cancer.